El acceso a medicamentos en América Latina: el desafío futuro

Argentina Ministry of Health website. Health guarantees the provision of medicines for patients with HIV throughout the country. http://www.msal.gob.ar/sida/index.php?option=com_content&view=article&id=578:salud-garantiza-la-provision-de-medicamentos-para-pacientes-con-vih-de-todo-el-pais&catid=6:destacados-slide578. Accessed January 27, 2020.
Beltran C. Workshop results and annual report: responses to HIV and migration in latin america: current challenges and strategies for the future. Presented at: International AIDS Society (IAS) 2019 conference; April 3, 2019; Bogotá, Colombia. Oral presentation.
Busse R, Schreyögg J, Gericke C. Analyzing changes in health financing arrangements in high-income countries: a comprehensive framework approach. HNP. 2007:1-55.
Culyer A, McCabe C, Briggs A, et al. Searching for a threshold, not setting one: the role of the national institute for health and clinical excellence. J Health Serv Res Policy. 2007;12:56-58.
Developed by the DHHS panel on antiretroviral guidelines for adults and adolescents – a working group of the office of AIDS research advisory council (OARAC). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. AIDSinfo website. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Last updated December 18, 2019. Accessed January 28, 2020.
Directorate of AIDS, STD, Hepatitis and TB, Ministry of Health Government, Ministry of Health and Social Development of the Nation. Recommendations for the start of antiretroviral treatment in adults with HIV-1 infection: summary for health teams that assist people in the public system. Argentina, 2019. http://www.msal.gob.ar/images/stories/bes/graficos/0000001562cnt-2019-09_recomendaciones-para-inicio-tratamiento-antirretroviral-adultos-infeccion-por-vih-1.pdf. Accessed January 28, 2020.
Eichler HG, Bloechl-Daum B, Abadie E, et al. Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov. 2010;9:277-291.
European AIDS Clinical Society (EACSA) guidelines. EACS society website. https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf. Version 10.0. November 2019. Accessed January 28, 2020.
Garrison LP, Neuman PJ, Willie RJ, et al. A health economics approach to US value assessment frameworks-summary and recommendations of the ISPOR special task force report [7]. Value in Health. 2018;21:161-165.
GeSIDA consensus document/national AIDS plan regarding antiretroviral treatment in adults infected by the human immunodeficiency virus. http://gesida-seimc.org/wp-content/uploads/2019/02/Guia_Tar_Gesida_Ene_2019.pdf. Update January 2019. Accessed January 28, 2020.
Guest foundation website. What is HIV and how is it detected? 2020. https://www.huesped.org.ar/informacion/vih/que-es-y-como-se-detecta/. Accessed January 27, 2020.
Martinez Buitrago E. Integrase inhibitors in Latin America: ‘Others’. Presented at: II Conference: Improving Standards in HIV Care; December 15-17, 2019; Santiago Chile.
Mauskopf J, Earnshaw SR. Introduction to budget-impact analysis. In: Mauskopf J, Earnshaw SR, editors. Budget-impact analysis of health care interventions: a practical guide. 1st ed. Cham: Switzerland. Springer International Publishing AG; 2017:1-10.
Ministry of Health of the Nation. Bulletin on HIV, AIDS and STIs in Argentina. 2019; Number 36: Year XXII.
Ministry of Health website. HIV newsletter, AIDS and STIs in Argentina 2018. http://www.msal.gob.ar/images/stories/bes/graficos/0000001385cnt-2018-12-20_boletin-epidemiologico-vih-sida-its_n35.pdf. Accessed January 27, 2020.
Noyes K, Holloway RG. Evidence from Cost-Effectiveness Research. NeuroRx. 2004;1:348-355.
Pichon-Riviere A, Augustovski F, Garcia-Marti S, et al. The efficiency path: an estimation of cost-effectiveness thresholds for 185 countries based on per capita health expenditures and life expectancy. Value Health. 2015;18:A335-A766.
Roche N, Reddel HK, Agusti A, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013;1:e29-e30.
Sachs JD. World Health Organization website. Macroeconomics and health: investing in health for economic development. Report of the commission on macroeconomics and health. Presented on December 2001. Accessed January 30, 2020.
Schnipper LE, et al. American Society of Clinical Oncology Statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;2563-2577.
Secretary of government website. Official newspaper of the federation. Decree whereby various provisions of the Health Supplies Regulation are reformed and added. http://dof.gob.mx/nota_detalle.php?codigo=5214882&fecha=19/10/2011. Published October 2011. Accessed on January 31, 2020.
Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17:5-14.
UNAIDS 2018 website. Global AIDS update 2018. Miles to go: closing gaps, breaking barriers, righting injustices. https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf. Accessed January 27, 2020.
UNAIDS website. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf. Revised January 1, 2017. Accessed January 29, 2020.
World Health Organization (WHO) website. Health financing for universal coverage. Universal coverage - three dimensions. https://www.who.int/health_financing/strategy/dimensions/en/. Accessed January 30, 2020.

WebMD Global exige que todas las personas que tengan control sobre el contenido de una de sus actividades educativas declaren cualquier relación económica relevante que se haya producido en los últimos 12 meses y que pudiera crear un conflicto de intereses.

Expositores

Dr. Andrés Pichón-Riviere, MSc, PhD

Director ejecutivo
Instituto de Efectividad Clínica y Sanitaria (IECS)
Profesor de Salud Pública
Universidad de Buenos Aires
Investigador del CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas)
Director del IECS y del Centro Colaborador de la OMS en Evaluación de Tecnologías en Salud

Disclosures

Conflicto de intereses: el Dr. Andrés Pichón-Riviere, MSc, PhD, ha declarado que no tiene ningún conflicto de intereses económico pertinente.

Dr. Federico Augustovski, MSc, PhD

Director del Departamento de Evaluación de Tecnologías Sanitarias y Economía de la Salud
Instituto de Efectividad Clínica y Sanitaria (IECS)
Profesor de Salud Pública
Universidad de Buenos Aires
Expresidente de ISPOR, 2019-2020

Disclosures

Conflicto de intereses: el Dr. Federico Augustovski, MSc, PhD, ha declarado que no tiene ningún conflicto de intereses económico pertinente.

Dr. Gustavo Lopardo

FUNCEI
Hospital Bernardo Houssay, Vicente López
Universidad de Buenos Aires
Buenos Aires (Argentina)

Disclosures

Conflicto de intereses: el Dr. Gustavo Lopardo ha declarado que no tiene ningún conflicto de intereses económico relevante.

Dra. Isabel Cassetti

Directora médica
Helios Salud (Centro ambulatorio especializado en VIH)
Buenos Aires (Argentina)

Disclosures

Conflicto de intereses: la Dra. Isabel Cassetti ha declarado las siguientes relaciones económicas pertinentes:
Ha fungido como asesora o consultora para: Merck Sharp & Dohme.
Ha fungido como conferenciante o miembro de una agencia de conferenciantes para: Gilead; Janssen; Merck Sharp & Dohme y ViiV.
Ha recibido becas para investigación clínica de: Janssen; Merck Sharp & Dohme y ViiV.

Editor

Jason Luis Quinones, PhD

Director de contenido científico, Medscape, LLC

Disclosures

Conflicto de intereses: Jason Luis Quinones, PhD ha declarado que no tiene ningún conflicto de intereses económico pertinente.

Shanthi Voorn, PhD

Directora de formación médica, Medscape, LLC

Disclosures

Conflicto de intereses: Shanthi Voorn, PhD, ha declarado que no tiene ningún conflicto de intereses económico pertinente.

Revisora de contenido

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Directora clínica asociada de CME

Disclosures

Conflicto de intereses: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, ha declarado que no tiene ningún conflicto de intereses económico pertinente.